Lorcaserin Extended-Release Tablets and Pms-Sodium Polystyrene Sulfonate
Determining the interaction of Lorcaserin Extended-Release Tablets and Pms-Sodium Polystyrene Sulfonate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Pneumococcal 13-valent conjugate vaccine
- Lorcaserin Extended-Release Tablets-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Lorcaserin Extended-Release Tablets-Pneumococcal Conjugate Vaccine (13-Valent)
- Lorcaserin Extended-Release Tablets-Pneumococcal Conjugate Vaccine (7-Valent)
- Lorcaserin Extended-Release Tablets-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Lorcaserin Extended-Release Tablets-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Pms-Sodium Polystyrene Sulfonate-Lorcaserin Hydrochloride
- Pms-Sodium Polystyrene Sulfonate-Lorcaserin Tablets
- Pms-Sodium Polystyrene Sulfonate-Lorcet
- Pms-Sodium Polystyrene Sulfonate-Lorcet Plus
- Pms-Sodium Polystyrene Sulfonate-Lorcet Tablets
- Pms-Sodium Polystyrene Sulfonate-Lorlatinib